Novavax: New Chapter, Questions Remain
Summary: Novavax, Inc. secured a lucrative deal with Sanofi, receiving potentially $1.2 billion in cash
Summary: Novavax, Inc. secured a lucrative deal with Sanofi, receiving potentially $1.2 billion in cash
Summary: Novavax has seen a surge in stock price due to recent COVID-19 and bird
Summary: Novavax announced Q1 2024 results with a beat on EPS and a miss on
Summary: Novavax, Inc.’s Sanofi partnership provides much-needed financial support via upfront and milestone payments, stabilizing